Position in JNJ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,611,065
+$97,978 QoQ
Shares Held
10,281
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#2,111
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026OAK ASSOCIATES LTD /OH/ holds $89,054,137 across 8 Drug Manufacturers - General names. JNJ ranks #5 (2.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
109,731 | $39,735,789 | |
| 2 | NVS |
Novartis AG
|
155,362 | $24,348,332 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
80,646 | $10,188,815 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
129,790 | $7,478,499 | |
| 5 | JNJ |
Johnson & Johnson
This page
|
10,281 | $2,611,065 | |
| 6 | MRK |
Merck & Co., Inc.
|
16,835 | $2,163,297 | |
| 7 | LLY |
ELI LILLY & Co
|
1,170 | $1,403,333 | |
| 8 | NVO |
Novo Nordisk A S
|
23,467 | $1,125,007 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,611,065 | 10,281 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,513,087 | 10,281 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $2,127,652 | 10,281 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $1,943,757 | 10,483 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,601,278 | 10,483 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,738,500 | 10,483 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,472,665 | 10,183 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,650,256 | 10,183 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,488,347 | 10,183 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $1,610,848 | 10,183 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $1,596,083 | 10,183 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,361,099 | 8,739 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,413,375 | 8,539 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $1,447,545 | 9,339 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $2,297,863 | 13,008 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $2,124,986 | 13,008 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $1,622,973 | 9,143 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,621,300 | 9,148 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $1,564,948 | 9,148 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $1,477,402 | 9,148 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,507,041 | 9,148 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $1,503,473 | 9,148 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $1,438,925 | 9,143 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $1,361,209 | 9,143 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,285,780 | 9,143 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $1,198,921 | 9,143 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||